CaixaBank, S.A.’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$286K Hold
4,352
– – ﹤0.01% 388
2026
Q2
$324K Hold
4,352
– – ﹤0.01% 380
2026
Q1
$323K Buy
+4,352
New +$315K ﹤0.01% 382

Other funds holding BBIO

CaixaBank, S.A.'s BBIO Position: Q3 2026 in Review

CaixaBank, S.A. held its BridgeBio Pharma (BBIO) position steady in Q3 2026 at 4,352 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #388.

CaixaBank, S.A. first reported a position in BBIO in Q1 2026 and has held it in 3 quarters since. The position peaked at $324K in Q2 2026. 465 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • CaixaBank, S.A. held 4,352 shares of BridgeBio Pharma worth $286K as of Q3 2026.
  • CaixaBank, S.A. left its BridgeBio Pharma share count unchanged in Q3 2026.
  • BridgeBio Pharma made up ﹤0.01% of CaixaBank, S.A.'s portfolio in Q3 2026, its #388 holding.
  • CaixaBank, S.A. first reported a position in BridgeBio Pharma in Q1 2026 and has held it in 3 quarters since.
  • CaixaBank, S.A.'s BridgeBio Pharma position peaked at $324K in Q2 2026.
  • 465 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on CaixaBank, S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.